Abiopharma

Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

VULCAN SHARPENS AGGREGATES FOCUS: EXITS CALIFORNIA CONCRETE, EXPANDS AGGREGATES FOOTPRINT IN DALLAS-FORT WORTH AND INTO COLORADO

Devon Announces Results of Early Participation in Private Exchange Offers and Consent Solicitations and Extension of Deadline to Receive Total Exchange Consideration

AECOM awarded nationwide U.S. Department of Homeland Security contract to support critical infrastructure modernization

SUNation Energy and Suniva Enter Definitive Merger Agreement, Creating a Platform for American Solar Manufacturing and Services Leadership

Mandatory Cash Dividend/ Distribution:

Extraordinary/ Special General Meeting:

Pfizer Inc. - U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need